|
1) Zhou YT, Grayburn P, Karim A, et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A. 2000; 97: 1784-9
|
|
|
|
2) Ng AC, Delgado V, Bertini M, et al. Myocardial steatosis and biventricular strain and strain rate imaging in patients with type 2 diabetes mellitus. Circulation. 2010; 122: 2538-44
|
|
|
|
|
|
3) Brindley DN, Kok BP, Kienesberger PC, et al. Shedding light on the enigma of myocardial lipotoxicity: the involvement of known and putative regulators of fatty acid storage and mobilization. Am J Physiol Endocrinol Metab. 2010; 298: E897-E908
|
|
|
|
|
|
4) Sawicki G, Leon H, Sawicka J, et al. Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury: a new intracellular target for matrix metalloprotei-nase-2. Circulation. 2005; 112: 544-52
|
|
|
|
|
|
5) Fang KM, Lee AS, Su MJ, et al. Free fatty acids act as endogenous ionophores, resulting in Na＋ and Ca2＋ influx and myocyte apoptosis. Cardiovasc Res. 2008; 78: 533-45
|
|
|
|
|
|
6) Tsutsui H, Kinugawa S, Matsushima S, et al. Mitochondrial oxidative stress and dysfunction in myocardial remodelling. Cardiovasc Res. 2009; 81: 449-56
|
|
|
|
|
|
7) Borradaile NM, Han X, Harp JD, et al. Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death. J Lipid Res. 2006; 47: 2726-37
|
|
|
|
|
|
8) Borradaile NM, Buhman KK, Listenberger LL, et al. A critical role for eukaryotic elongation factor 1A-1 in lipotoxic cell death. Mol Biol Cell. 2006; 17: 770-8
|
|
|
|
|
|
9) Brookheart RT, Michel CI, Listenberger LL, et al. The non-coding RNA gadd7 is a regulator of lipid-induced oxidative and endoplasmic reticulum stress. J Biol Chem. 2009; 284: 7446-54
|
|
|
|
|
|
10) Finck BN, Lehman JJ, Leone TC, et al. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J Clin Invest. 2002; 109: 121-30
|
|
|
|
|
|
11) Yagyu H, Chen G, Yokoyama M, et al. Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy. J Clin Invest. 2003; 111: 419-26
|
|
|
|
|
|
12) Haemmerle G, Lass A, Zimmermann R, et al. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science. 2006; 312: 734-7
|
|
|
|
|
|
13) Perman JC, Boström P, Lindbom M, et al. The VLDL receptor promotes lipotoxicity and increases mortality in mice following an acute myocardial infarction. J Clin Invest. 2011; 121: 2625-40
|
|
|
|
|
|
14) Chiu HC, Kovacs A, Ford DA, et al. A novel mouse model of lipotoxic cardiomyopathy. J Clin Invest. 2001; 107: 813-22
|
|
|
|
|
|
15) Liu L, Shi X, Bharadwaj KG, et al. DGAT1 expression increases heart triglyceride content but ameliorates lipotoxicity. J Biol Chem. 2009; 284: 36312–23
|
|
|
|
|
|
16) Glenn DJ, Wang F, Nishimoto M, et al. A murine model of isolated cardiac steatosis leads to cardiomyopathy. Hypertension. 2011; 57: 216-22
|
|
|
|
|
|
17) Suzuki J, Ueno M, Uno M, et al. Effects of hormone-sensitive lipase-disruption on cardiac energy metabolism in response to fasting and refeeding. Am J Physiol Endocrinol Metab. 2009; 297: E1115-24
|
|
|
|
|
|
18) Escary JL, Choy HA, Reue K, et al. Paradoxical effect on atherosclerosis of hormone-sensitive lipase overexpression in macrophages. J Lipid Res. 1999; 40: 397-404
|
|
|
|
|
|
19) Winzell MS, Svensson H, Enerbäck S, et al. Pancreatic beta-cell lipotoxicity induced by overexpression of hormone-sensitive lipase. Diabetes. 2003; 52: 2057-65
|
|
|
|
|
|
20) Reid BN, Ables GP, Otlivanchik OA, et al. Hepatic overexpression of hormone-sensitive lipase and adipose triglyceride lipase promotes fatty acid oxidation, stimulates direct release of free fatty acids, and ameliorates steatosis. J Biol Chem. 2008; 283: 13087-99
|
|
|
|
|
|
21) Ueno M, Suzuki J, Zenimaru Y, et al. Cardiac overexpression of hormone-sensitive lipase inhibits myocardial steatosis and fibrosis in streptozotocin diabetic mice. Am J Physiol Endocrinol Metab. 2008; 294: E1109-18
|
|
|
|
|
|
22) Hammer S, van der Meer RW, Lamb HJ, et al. Progressive caloric restriction induces dose-dependent changes in myocardial triglyceride content and diastolic function in healthy men. J Clin Endocrinol Metab. 2008; 93: 497-503
|
|
|
|
|
|
23) van der Meer RW, Hammer S, Smit JW, et al. Short-term caloric restriction induces accumulation of myocardial triglycerides and decreases left ventricular diastolic function in healthy subjects. Diabetes. 2007; 56: 2849-53
|
|
|
|
|
|
24) Yang J, Sambandam N, Han X, et al. CD36 deficiency rescues lipotoxic cardiomyopathy. Circ Res. 2007; 100: 1208-17
|
|
|
|
|
|
25) Duncan JG, Bharadwaj KG, Fong JL, et al. Rescue of cardiomyopathy in peroxisome proliferator-activated receptor-alpha transgenic mice by deletion of lipoprotein lipase identifies sources of cardiac lipids and peroxisome proliferator-activated receptor-alpha activators. Circulation. 2010; 121: 426-35
|
|
|
|
|
|
26) Park TS, Hu Y, Noh HL, et al. Ceramide is a cardiotoxin in lipotoxic cardiomyopathy. J Lipid Res. 2008; 49: 2101-12
|
|
|
|
|
|
27) Asai T, Okumura K, Takahashi R, et al. Combined therapy with PPARalpha agonist and L-carnitine rescues lipotoxic cardiomyopathy due to systemic carnitine deficiency. Cardiovasc Res. 2006; 70: 566-77
|
|
|
|
|
|
28) Son NH, Park TS, Yamashita H, et al. Cardiomyocyte expression of PPARgamma leads to cardiac dysfunction in mice. J Clin Invest. 2007; 117: 2791-801
|
|
|
|
|
|
29) Georgiadi A, Lichtenstein L, Degenhardt T, et al. Induction of cardiac Angptl4 by dietary fatty acids is mediated by peroxisome proliferator-activated receptor beta/delta and protects against fatty acid-induced oxidative stress. Circ Res. 2010; 106: 1712-21
|
|
|
|
|
|
30) Alvarez-Guardia D, Palomer X, Coll T, et al. PPARβ/δ activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells. Biochim Biophys Acta. 2011; 1811: 59-67
|
|
|
|
|
|
31) Cresser J, Bonen A, Chabowski A, et al. Oral administration of a PPAR-delta agonist to rodents worsens, not improves, maximal insulin-stimulated glucose transport in skeletal muscle of different fibers. Am J Physiol Regul Integr Comp Physiol. 2010; 299: R470-9
|
|
|
|
|